Autolus Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Autolus Therapeutics

05/05/2022 20:01

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 41 cents​​ per share for the quarter ended in March. The
mean expectation of nine analysts for the quarter was for a loss
of 48 cents per share.
    * Revenue fell 38.3% to $166.00 thousand from a year ago; 
analysts expected $282.86 thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 41 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Autolus Therapeutics PLC shares had fallen by 23.0% this
quarter and lost 38.2% so far this year.
    * The company reported a quarterly loss of $37.06 million.
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 07:01 p.m.  ​All
figures in US dollars unless otherwise stated